Advanced Viral Research (ADVR) Inactive 10-K2006 FY Annual report

Filed: 12 Mar 07, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	8th grade Avg

New words: abandon, abandoned, Abbott, acne, acute, add, admission, ancillary, antiviral, apparent, Australia, autoimmune, Bacitracin, background, Baylor, begun, behavior, Betadine, Bioscience, Bloomberg, Botter, broad, Bulleting, bylaw, Canadian, candidate, cardiovascular, Carolina, chance, chemo, chose, chronic, commuting, COMPENSATORY, composed, construed, contingent, contrast, counting, creation, customary, Dakin, decease, dendritic, dosage, driven, easily, Ellistion, Elliston, endothelial, equitable, Europe, exposure, extremely, factor, fail, FAS, footnote, formulation, gastroenterology, Genentech, Global, GOVERNACE, heal, healing, hierarchy, hydrogen, hypoglycemic, illiquid, immaterial, indirectly, intralesional, Isadore, Izzy, Kensington, KGA, launch, lean, lethargy, link, Lockup, McGill, merit, merited, Merix, minimize, motivate, NASD, NE, Neosporine, Nephew, opposed, Pablo, penalty, peroxide, philosophy, pig, Pike, pilot, preliminarily, prescription, preserve, pronounced, pronouncement, properly, protein, qualitative, quantify, quantifying, quantitative, Questionnaire, ranked, reaching, regeneration, Regranex, repair, requisite, resell, retrieval, role, SAB, satisfaction, satisfactory, Scolnick, size, Smith, solution, sophisticated, spray, startup, Stephen, strategy, strong, structuring, sulfadiazine, superior, symbol, talent, teaching, team, tenure, therewith, tissue, transplantation, Treasury, uncorrected, unissued, unrecognized, vascular, VEGF, vehicle, version, Web, wound, yearly, Yorkville

Removed: advisory, annum, attorney, awarded, Beiley, beneficiary, Berlin, closer, College, combination, combined, consolidate, david, deficiency, dollar, Enforcement, Fine, Florida, Forest, graduate, granddaughter, grandson, granting, Hartman, hospital, HPV, Hunter, Jessica, lock, markdown, markup, nancy, Oxford, papilloma, Paul, recommending, Regional, rheumatoid, Sacher, sant, seligman, Shore, standing, syndrome, treasurer, trustee, van, variable, Waldman, Zelman

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

ADVR similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Advanced Viral Research Corp. (the “Company”) on Form 10-K for the period ending December 31, 2006 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, the undersigned, certify, pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

	(1)		The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

	(2)		The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: March 12, 2007	/s/ Martin Bookman
	Martin Bookman, Acting Chief Financial Officer

This certification accompanies this Report on Form 10-K pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.